Archive - June 2018
Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat
CR UK tests Asterias’ novel lung cancer immunotherapy jab
SMC approves funding for six new therapies on the NHS
Allergan’s experimental migraine drug hits trial targets
Researchers to trial prostate cancer saliva test
U.S. FDA Grants Priority Review to Astellas’ New Drug Application for Gilteritinib for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
FDA Accepts Larotrectinib New Drug Application and Grants Priority Review
Sage Therapeutics Announces FDA Acceptance of NDA Filing and Grant of Priority Review for Brexanolone IV in the Treatment of Postpartum Depression